Search results for "globin"

showing 10 items of 734 documents

Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non–ST-segment elevation acute coronary syndromes

2003

Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703–1708. 2. Senior R, Kaul S, Soman P, Lahiri A. Power-Doppler contrast echocardiography—a new technique for Assessing myocardial perfusion. Am Heart J 2000; 139:245–251. 3. Picano E, Parodi O, Lattanzi F, Sambuceti G, Andrade MJ, Marzullo P, Giorgetti A, Salvadori P, Marzilli M, Distante A. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography. Circulation 1994;89:753–761. 4. Jayaweera AR, Wei K, Coggins M, Bin…

AdultMalemedicine.medical_specialtyTime FactorsCoronary DiseaseFractional flow reserveSensitivity and SpecificityHospitals UniversityCoronary artery diseaseElectrocardiographyRisk FactorsCause of DeathInternal medicineSpect imagingHumansMedicineFalse Positive ReactionsHospital MortalityAgedAged 80 and overAnalysis of VariancebiologyMyoglobinbusiness.industryMiddle AgedPrognosismedicine.diseaseTroponinTroponinDipyridamolemedicine.anatomical_structureCoronary stealSpainbiology.proteinCardiologyFemaleTriageCardiology and Cardiovascular MedicinebusinessPerfusionBiomarkersArterymedicine.drugThe American Journal of Cardiology
researchProduct

Frequent blood flow restricted training not to failure and to failure induces similar gains in myonuclei and muscle mass

2021

The purpose of the present study was to compare the effects of short-term high-frequency failure vs non-failure blood flow–restricted resistance exercise (BFRRE) on changes in satellite cells (SCs), myonuclei, muscle size, and strength. Seventeen untrained men performed four sets of BFRRE to failure (Failure) with one leg and not to failure (Non-failure; 30-15-15-15 repetitions) with the other leg using knee-extensions at 20% of one repetition maximum (1RM). Fourteen sessions were distributed over two 5-day blocks, separated by a 10-day rest period. Muscle samples obtained before, at mid-training, and 10-day post-intervention (Post10) were analyzed for muscle fiber area (MFA), myonuclei, an…

AdultMalemedicine.medical_specialtyTime FactorsSatellite Cells Skeletal MuscleRestPhysical ExertionSensationPhysical Therapy Sports Therapy and RehabilitationIsometric exercise030204 cardiovascular system & hematologyQuadriceps MuscleMuscle hypertrophy03 medical and health sciences0302 clinical medicineIsometric ContractionInternal medicineOne-repetition maximumHumansMedicineOrthopedics and Sports MedicineMuscle StrengthCreatine KinaseCell ProliferationUltrasonographyCell NucleusLegPalpationKaatsuElectromyographyMyoglobinbusiness.industryOvertrainingResistance TrainingMyalgiaOrgan Size030229 sport sciencesBlood flowmedicine.diseaseOverreachingVDP::Medisinske Fag: 700::Idrettsmedisinske fag: 850Muscle Fibers Slow-TwitchRegional Blood FlowCell Nucleus SizeMuscle Fibers Fast-TwitchCardiologybusinessSupercompensation
researchProduct

Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure

2021

Systemic inflammation is a characteristic feature of pulmonary tuberculosis (PTB). Whether systemic inflammation is associated with treatment failure in PTB is not known. Participants, who were newly diagnosed, sputum smear and culture positive individuals with drug-sensitive PTB, were treated with standard anti-tuberculosis treatment and classified as having treatment failure or microbiological cure. The plasma levels of acute phase proteins were assessed at baseline (pre-treatment). Baseline levels of C-reactive protein (CRP), alpha-2 macroglobulin (a2M), Haptoglobin and serum amyloid P (SAP) were significantly higher in treatment failure compared to cured individuals. ROC curve analysis …

AdultMalemedicine.medical_specialtyTuberculosisImmunologyAntitubercular AgentsSystemic inflammationGastroenterologyCohort StudiesInternal medicinemedicineHumansImmunology and AllergyProspective StudiesTreatment FailureTuberculosis PulmonaryOriginal ResearchHaptoglobinsbiologybusiness.industryHaptoglobinAcute-phase proteinArea under the curveRC581-607Middle Agedmedicine.diseasePregnancy-Associated alpha 2-MacroglobulinsMacroglobulinSerum Amyloid P-ComponentC-Reactive ProteintuberculosisROC CurveinflammationTB treatmentacute phase proteinsbiology.proteinbiomarkerSputumBiomarker (medicine)FemaleImmunologic diseases. Allergymedicine.symptombusinessBiomarkersAcute-Phase ProteinsFrontiers in Immunology
researchProduct

Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus

2010

The aim of the present study was to compare the effect of PIO (pioglitazone) or GLIM (glimepiride) on erythrocyte deformability in T2DM (Type 2 diabetes mellitus). The study covered 23 metformin-treated T2DM patients with an HbA1c (glycated haemoglobin) >6.5%. Patients were randomized to receive either PIO (15 mg, twice a day) or GLIM (1 mg, twice a day) in combination with metformin (850 mg, twice a day) for 6 months. Blood samples were taken for the measurement of fasting glucose, HbA1c, fasting insulin, intact proinsulin, adiponectin and Hct (haematocrit). In addition, the erythrocyte EI (elongation index) was measured using laser diffractoscopy. Both treatments significantly impr…

AdultMalemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentType 2 diabetesInsulin resistanceErythrocyte DeformabilityInternal medicineDiabetes mellitusHumansHypoglycemic AgentsMedicineAgedProinsulinGlycated HemoglobinPioglitazoneAdiponectinbusiness.industryInsulinnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseMetforminGlimepirideSulfonylurea CompoundsEndocrinologyDiabetes Mellitus Type 2Drug Therapy CombinationFemaleThiazolidinedionesStress MechanicalbusinessPioglitazonemedicine.drugClinical Science
researchProduct

Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia

2021

In β-thalassaemia, the severity of inherited β-globin gene mutations determines the severity of the clinical phenotype at presentation and subsequent transfusion requirements. However, data on associated long-term outcomes remain limited. We analysed data from 2109 β-thalassaemia patients with available genotypes in a global database. Genotype severity was grouped as β0 /β0 , β0 /β+ , β+ /β+ , β0 /β++ , β+ /β++ , and β++ /β++ . Patients were followed from birth until death or loss to follow-up. The median follow-up time was 34·1 years. Mortality and multiple morbidity outcomes were analyzed through five different stratification models of genotype severity groups. Interestingly, β0 and β+ mu…

AdultMalemedicine.medical_specialtyphenotypegenotypemorbidityKaplan-Meier Estimatebeta-GlobinsGene mutationβ thalassaemiaGlobal HealthGastroenterologySeverity of Illness IndexsurvivalCohort StudiesYoung AdultInternal medicineGenotypemedicineLong term outcomesOdds RatioHumansAllelesgenotype; morbidity; mortality; phenotype; survivalProportional Hazards Modelsbusiness.industrybeta-ThalassemiaDisease ManagementHematologyPrognosisPhenotypemortalityConfidence intervalPopulation SurveillanceCohortMutationFemaleRisk of deathbusinessFollow-Up Studies
researchProduct

Multimodal Device for Real-Time Monitoring of Skin Oxygen Saturation and Microcirculation Function

2019

The present study introduces a recently developed compact hybrid device for real-time monitoring of skin oxygen saturation and temperature distribution. The prototype involves a snapshot hyperspectral camera, multi-wavelength illuminator, thermal camera, and built-in computer with custom-developed software. To validate this device in-vivo we performed upper arm vascular occlusion on eight healthy volunteers. Palm skin oxygen saturation maps were analyzed in real-time using k-means segmentation algorithm and two-layer optical diffuse model. The prototype system demonstrated a satisfying performance of skin hyperspectral measurements in the spectral range of 507&ndash

AdultMaterials sciencehyperspectral imaginglcsh:BiotechnologyClinical BiochemistryComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONmicrocirculationmultimodal imaging02 engineering and technologyProof of Concept Study01 natural sciencesskin mottlingArticleMicrocirculation010309 opticsSoftwarelcsh:TP248.13-248.650103 physical sciencesHealthy volunteersHumansSegmentationMonitoring PhysiologicSkinHemoglobin SaturationMultimodal imagingHybrid devicebusiness.industryTemperatureHyperspectral imagingGeneral Medicine021001 nanoscience & nanotechnologyOxygenskin oxygen saturation0210 nano-technologybusinessBiomedical engineeringBiosensors
researchProduct

Photobleaching effects onin vivoskin autofluorescence lifetime

2015

The autofluorescence lifetime of healthy human skin was measured using excitation provided by a picosecond diode laser operating at a wavelength of 405 nm and with fluorescence emission collected at 475 and 560 nm. In addition, spectral and temporal responses of healthy human skin and intradermal nevus in the spectral range 460 to 610 nm were studied before and after photobleaching. A decrease in the autofluorescences lifetimes changes was observed after photobleaching of human skin. A three-exponential model was used to fit the signals, and under this model, the most significant photoinduced changes were observed for the slowest lifetime component in healthy skin at the spectral range 520 …

AdultTime FactorsMaterials scienceLightPhotochemistryBiomedical EngineeringHuman skinAbsorption (skin)LipofuscinBiomaterialsNuclear magnetic resonanceFlavinsIntradermal NevusmedicineHumansNevusskin and connective tissue diseasesPhospholipidsSkinInflammationPhotobleachingbusiness.industryEquipment DesignMiddle AgedHandmedicine.diseasePhotobleachingFluorescenceAtomic and Molecular Physics and OpticsElectronic Optical and Magnetic MaterialsAutofluorescenceSpectrometry FluorescenceOxyhemoglobinsPicosecondFlavin-Adenine DinucleotideNevus IntradermalOptoelectronicsbusinessJournal of Biomedical Optics
researchProduct

Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes

2002

Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it.We monitored 75 adolescents and young adults who had had type 1 diabetes with normal urinary albumin excretion and blood pressure for more than five years. Ambulatory blood-pressure monitoring was used to assess blood pressure at the initial evaluation and about two years later, at which time all subjects had normal urinary albumin excretion. Subsequently, subjects were monitored for the development of microalbuminuria.Microalbuminuria developed in 14 subjects, whereas the o…

Adultmedicine.medical_specialtyAdolescentBlood PressureExcretionInternal medicineDiabetes mellitusmedicineAlbuminuriaHumansProspective StudiesGlycated HemoglobinType 1 diabetesProteinuriabusiness.industryAlbuminGeneral MedicineBlood Pressure Monitoring Ambulatorymedicine.diseaseCircadian RhythmDiabetes Mellitus Type 1EndocrinologyBlood pressureAmbulatoryDisease ProgressionCardiologyMicroalbuminuriamedicine.symptombusinessBiomarkersNew England Journal of Medicine
researchProduct

Mean maternal second-trimester hemoglobin concentration and outcome of pregnancy: a population-based study.

2008

Both anemia and the lack of physiological maternal plasma volume expansion during the second trimester are associated with higher maternal morbidity and poor fetal outcome. Mean hemoglobin levels between the 14th and 30th gestational weeks were calculated in 4985 consecutive pregnant women and were correlated with outcome data of pregnancy. It was found that 9.4% of participants (n = 3959) had normal pregnancy outcome. Mean maternal hemoglobin levels were significantly lower in women with a normal pregnancy (11.96 ± 0.94 g/dL) compared with women who had adverse outcome events (preeclampsia, n = 423, 12.5 ± 1.0 g/dL, P < .0001; early birth, n = 464, 12.2 ± 1.01 g/dL, P < .0001; low b…

Adultmedicine.medical_specialtyAnemiaPopulationMothersPreeclampsiaHemoglobinsPregnancymedicineHumansRisk factoreducationGynecologyeducation.field_of_studyPregnancybusiness.industryPregnancy OutcomeHematologyGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalPregnancy ComplicationsLow birth weightPregnancy Trimester SecondWomen's HealthFemalemedicine.symptombusinessClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes.

2021

Abstract Background and aim To study the association between achievement of guideline-defined treatment targets on HbA1c, low-density lipoproteins (LDL-C), and blood pressure with the progression of diabetic complications in patients with type 1 diabetes (T1D). Methods The study included 355 patients at baseline and 114 patients with follow-up data after 3–5 years. Outcome variables were the progression of diabetic kidney disease, retinopathy, or cardiovascular disease (CVD). We used logistic regression and other machine learning algorithms (MLA) to model the association of achievement of treatment targets and probability of progression of complications. Results Achievement of the target bl…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismDiseaseLogistic regressionOddsDiabetes ComplicationsMachine LearningEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansDiabetic NephropathiesGlycated HemoglobinType 1 diabetesbusiness.industryCholesterol LDLMiddle Agedmedicine.diseaseLatviaBlood pressureDiabetes Mellitus Type 1Treatment OutcomeCardiovascular DiseasesHypertensionDisease ProgressionComplicationbusinessRetinopathyFollow-Up StudiesJournal of diabetes and its complications
researchProduct